Daiwa Downgrades Pfizer (PFE) to Neutral Following Full-Year 2025 Earnings
Pfizer Inc. (NYSE:PFE) is one of the most promising low-cost stocks to buy now.
Pfizer Inc (PFE)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 51,952,106 | $1,293,607,468 | +6% | 0.44% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 12,661,914 | $315,281,659 | +82% | 0.29% |
| 3. | Squarepoint Ops LLC Maxime Fortin (Cio) | 9,683,266 | $241,113,323 | -6% | 0.26% |
| 4. | Diamond Hill Capital Ric Dillon | 9,439,267 | $235,037,748 | -14% | 1.2% |
| 5. | Pzena Investment Management Richard S. Pzena | 6,526,800 | $162,517,320 | -2% | 0.49% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.65 | 19,457 | $499,072.05 | 27,707 | 2025-02-13 | Filing | |
| $28.24 | 1,000 | $28,240.00 | 10,000 | 2024-10-30 | Filing | |
| $26.47 | 3,000 | $79,401.00 | 9,000 | 2023-12-15 | Filing | |
| $38.58 | 1,000 | $38,580.00 | 6,000 | 2023-05-08 | Filing | |
| $38.43 | 1,000 | $38,425.00 | 5,000 | 2023-05-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.93 | 2,500 | $64,825.00 | 11,850 | 2025-03-04 | Filing | |
| $28.66 | 5,154 | $147,713.64 | 8,582 | 2024-08-13 | Filing | |
| $40.02 | 9,912 | $396,678.24 | 9,003 | 2023-03-15 | Filing | |
| $53.96 | 4,218 | $227,603.28 | 10,846 | 2022-06-07 | Filing | |
| $50.50 | 4,000 | $202,000.00 | 15,064 | 2022-05-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 541,346,182 | $13,479,519,929 | 0.2% | |
| 2. | 493,062,528 | $12,277,256,927 | 0.21% | |
| 3. | 300,445,164 | $7,481,084,584 | 0.25% | |
| 4. | 130,192,081 | $3,235,641,726 | 0.2% | |
| 5. | 89,113,604 | $2,218,928,830 | 0.13% |
News See All
Is Pfizer Inc. (PFE) One of the Best Medical Research Stocks to Buy According to Hedge Funds?
Pfizer Inc. (NYSE:PFE) is one of the best medical research stocks to buy according to hedge funds. Pfizer Inc. (NYSE:PFE) announced on February 6 that the U.S.
11 Most Promising Low-Cost Stocks to Buy Now
On February 7, Richard Bernstein, CEO of Richard Bernstein Advisors, joined 'The Exchange' on CNBC to discuss the state of equity markets, assessing which stocks are growing fast and trading cheaply.
10 Best Medical Research Stocks to Buy According to Hedge Funds
On January 27, Sarah James, Cantor Fitzgerald analyst, appeared on CNBC’s ‘Squawk on the Street’ to talk about the healthcare insurance sector and the stocks coming under pressure.
Pfizer (PFE) Closes 2025 on Solid Note, Returns $9.8B to Shareholders
Pfizer Inc. (NYSE:PFE) reported its Q4 2025 results on February 3. The company posted revenue of $17.56 billion, falling slightly by 1.1% from a year earlier.
Pfizer Inc. (PFE) Announces FDA's Grant of Priority Review for HYMPAVZI® (marstacimab) sBLA
Pfizer Inc. (NYSE:PFE) is one of the best healthcare stocks under $50 to invest in. Pfizer Inc. (NYSE:PFE) announced on February 6 that the U.S.
Dividend Champions, Contenders and Challengers list: 15 Highest Yielding Stocks
Dividend Champions are companies that have raised their dividends for at least 25 consecutive years and may not be part of the S&P 500.
12 Best Healthcare Stocks Under $50 to Invest In
On January 27, Jared Holz, healthcare equity strategist at Mizuho, appeared on CNBC’s 'Power Lunch' to talk about healthcare stocks and the new proposals around Medicare Advantage.
Pfizer Inc. (PFE): A Bull Case Theory
We came across a bullish thesis on Pfizer Inc. on Disruptive analytics’s Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on PFE.
Pfizer (PFE) Announces Positive Phase 2b Results for Obesity Drug Showing 12.30% Weight Loss
Pfizer Inc. (NYSE:PFE) is one of the best large cap stocks to buy under $50.
Hedge Fund Resource Center Billionaire Hedge Funds
